JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120951

Nifuroxazide, JAK/STAT signaling inhibitor

Be the first to review this product! Submit a review

|

(1 Publication)

MW 275.22 g/mol, Purity >98%. JAK/STAT signaling inhibitor. Nitrofuran antibiotic. Inhibits JAK2 and Tyk2 phosphorylation and subsequent downstream STAT3 inhibition (EC50 = 3 μM). Antidiarrheal. Shows little effect on Akt, NF-κB, JAK1, MAPK and Src signaling.
2 Images
Functional Studies - Nifuroxazide, JAK/STAT signaling inhibitor (AB120951)
  • FuncS

Unknown

Functional Studies - Nifuroxazide, JAK/STAT signaling inhibitor (AB120951)

FOX-NY cells were incubated at 37°C for 30 minutes with vehicle control (0 μM) and different concentrations of nifuroxazide (ab120951). Decreased expression of Stat3 (phospho Y705) (ab76315) in FOX-NY cells correlates with an increase in nifuroxazide concentration, as described in literature.

Whole cell lysates were prepared with RIPA buffer (containing protease inhibitors and sodium orthovanadate), 20 μg of each were loaded on the gel and the WB was run under reducing conditions. After transfer the membrane was blocked for an hour using 5% BSA before being incubated with ab76315 at 1/20000 dilution and ab8227 at 1 μg/ml overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP (ab97051) at 1/10000 dilution and visualised using ECL development solution.

Chemical Structure - Nifuroxazide, JAK/STAT signaling inhibitor (AB120951)
  • Chemical Structure

Lab

Chemical Structure - Nifuroxazide, JAK/STAT signaling inhibitor (AB120951)

2D chemical structure image of ab120951, Nifuroxazide, JAK/STAT signaling inhibitor

Key facts

CAS number

965-52-6

Purity

>98%

Form

Solid

form

Molecular weight

275.22 g/mol

Molecular formula

C<sub>1</sub><sub>2</sub>H<sub>9</sub>N<sub>3</sub>O<sub>5</sub>

Nature

Synthetic

Solubility

Soluble in DMSO to 100 mM

Biological description

JAK/STAT signaling inhibitor. Nitrofuran antibiotic. Inhibits JAK2 and Tyk2 phosphorylation and subsequent downstream STAT3 inhibition (EC50 = 3 μM). Antidiarrheal. Shows little effect on Akt, NF-κB, JAK1, MAPK and Src signaling.

IUPAC Name

4-Hydroxybenzoic acid 2-[(5-nitro-2-furanyl)methylene]hydrazide

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Product protocols

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

PloS one 20:e0315489 PubMed39883639

2025

IL-34 aggravates myocardial ischemia-reperfusion injury by upregulating the HMGB1-IL-17A-IL-6 axis through the JAK signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Ruisong Ma,Xiaochun Hu,Wenwen Fu,Xiaorong Hu
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com